K 130

Drug Profile

K 130

Alternative Names: K 120; K 137; K 138

Latest Information Update: 19 Nov 2001

Price : $50

At a glance

  • Originator Nonindustrial source
  • Class Diaminopyrimidines
  • Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Dermatitis herpetiformis; Mycobacterial infections

Most Recent Events

  • 19 Nov 2001 No-Development-Reported for Mycobacterial infections in Germany (Unknown route)
  • 19 Nov 2001 No-Development-Reported for Dermatitis herpetiformis in Germany (Unknown route)
  • 01 Sep 1999 An in vivo study has been added to the Bacterial Infections pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top